MISTMilestone Pharmaceuticals Inc.
1.055USD-2.31%Mkt Cap: 131.35M $P/E: —3d ago
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a pr…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap131.35M $
Enterprise Value116.36M $
Revenue (TTM)2.34M $
Gross Profit2.30M $
Net Income (TTM)-63.06M $
Revenue/Share0.0200 USD
Last Price1.055 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees38
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.33
PEG—
EV/EBITDA-1.49
EV/Revenue49.66
P/S54.73
P/B3.83
EPS (TTM)-0.62
EPS (Forward)-0.77
52W Range
1.0003% of range3.060
52W High3.060 USD
52W Low1.000 USD
Profitability
Gross Margin98.04%
Oper. Margin-4584.97%
EBITDA Margin0.00%
Profit Margin-4078.78%
ROE-150.97%
ROA-55.53%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-49.04M $
CapEx (TTM)302.00K $
FCF Margin-1779.23%
FCF Yield-31.74%
Net Debt-28.78M $
Net Debt/EBITDA0.37
Balance Sheet
Debt/Equity1.40
Current Ratio8.13
Quick Ratio7.87
Book Value/Sh0.2690 USD
Cash/Share1.211 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.857 USD
Upside (mean)+455.2%
Target Range2.000 USD – 8.000 USD
$2.000+455.2% to mean$8.000
# Analysts7
Ownership
Shares Out.124.50M
Float106.47M
Insiders0.70%
Institutions50.57%
Short Interest
Short Ratio12.9d
Short % Float12.69%
Short % Out.12.60%
Shares Short15.69M
Short (prev mo.)12.60M
Technical
SMA 501.215 (-13.2%)
SMA 2001.704 (-38.1%)
Beta0.98
S&P 52W Chg18.16%
Avg Vol (30d)1.39M
Avg Vol (10d)2.22M
Technical Indicators
RSI (14)38.1
MACD-0.0405
MACD Signal-0.0354
MACD Hist.-0.0050
BB Upper1.267 USD
BB Middle1.138 USD
BB Lower1.008 USD
BB Width22.77%
ATR (14)0.0740 USD
Vol Ratio (20d)1.15x